IL18 and neoplasm: The NLRP1 inflammasome has also been studied in the TME of multiple myeloma, where NLRP1 increases the production of MDSCs by sensing disturbances in hematopoietic stress or cellular homeostasis and responding by secreting IL-18, which leads to accelerated tumor progression (54).